Published in J Biol Chem on June 25, 1990
Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol (1995) 1.37
N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat Immunol (2010) 1.11
Lineage-restricted retention of a primitive immunoglobulin heavy chain isotype within the Dipnoi reveals an evolutionary paradox. Proc Natl Acad Sci U S A (2003) 1.10
Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity. PLoS One (2007) 1.05
Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States. Clin Vaccine Immunol (2013) 1.03
Recombinant human IgA expressed in insect cells. Proc Natl Acad Sci U S A (1994) 0.97
IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease. Glycoconj J (2013) 0.80
Core fucosylation of μ heavy chains regulates assembly and intracellular signaling of precursor B cell receptors. J Biol Chem (2011) 0.77
Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A (1977) 3.13
Tularaemia in Sheep. Can J Comp Med Vet Sci (1942) 2.81
The coding function of nucleotide sequences can be discerned by statistical analysis. J Theor Biol (1981) 2.61
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Production of functional chimaeric mouse/human antibody. Nature (1985) 2.35
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol (1984) 2.14
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Properties of recombination-deficient mutants of bacteriophage lambda. J Mol Biol (1970) 1.80
Structure and function of immunoglobulin domains. V. Binding, University of immunoglobulin G and fragments to placental membrane preparations. J Immunol (1976) 1.78
The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1. J Immunol (1976) 1.70
Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci U S A (1988) 1.70
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry (1981) 1.58
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
Gene replacement with one-sided homologous recombination. Mol Cell Biol (1992) 1.51
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science (1998) 1.46
A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography. J Immunol (1974) 1.44
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci U S A (1981) 1.41
IgM--molecular requirements for its assembly and function. Immunol Today (1989) 1.38
Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc Natl Acad Sci U S A (1991) 1.23
New att mutants of phage lambda. Virology (1976) 1.20
The identification of a previously unrecognized subcomponent of the first component of complement. J Immunol (1975) 1.18
The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase. J Immunol (1980) 1.18
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A (1990) 1.17
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
On the linkage between RNA processing and RNA translatability. J Biol Chem (1994) 1.14
B and T cells are not required for the viable motheaten phenotype. J Exp Med (1996) 1.14
Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. Mol Immunol (1996) 1.11
On the structure of polymeric IgM. Eur J Immunol (1988) 1.11
Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact. J Biol Chem (1987) 1.08
Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med (1988) 1.08
Complement fixing and macrophage opsonizing activities associated with beta2 microglobulin. Immunol Commun (1974) 1.08
Calcium binding properties of the C1 subcomponents C1q, C1r and C1s. FEBS Lett (1980) 1.07
Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes. J Immunol (1980) 1.07
Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. EMBO J (1989) 1.07
Analysis of hybridoma mutants defective in synthesis of immunoglobulin M. Somat Cell Mol Genet (1986) 1.06
Folding pathways of immunoglobulin domains. The folding kinetics of the Cgamma3 domain of human IgG1. Biochemistry (1979) 1.06
The structure and function of immunoglobulin domains: studies with beta-2-microglobulin on the role of the intrachain disulfide bond. Proc Natl Acad Sci U S A (1975) 1.05
Structure and function of immunoglobulin domains. VII. Studies on the structural requirements of human immunoglobulin G for granulocyte binding. J Immunol (1978) 1.05
Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1. J Immunol (1976) 1.04
Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res (1983) 1.03
Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region. Mol Cell Biol (1999) 1.03
Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J Biol Chem (1992) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J Immunol (1993) 1.02
Evidence for the domain hypothesis: location of the site of cytophilic activity toward guinea pig macrophages in the C H 3 homology region of human immunoglobulin G. J Immunol (1973) 1.02
The macromolecular structure of the first component of complement. J Immunol (1975) 1.01
The ultrastructure of C1t, a subcomponent of the first component of complement: an E.M. and ultracentrifuge study. J Immunol (1976) 1.01
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J Biol Chem (1999) 1.01
Homologous recombination between transferred and chromosomal immunoglobulin kappa genes. Mol Cell Biol (1988) 1.01
Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J Immunol (2000) 1.01
Immunoglobulin mu and gamma heavy chain classes are not determined by class-specific RNA-splicing enzymes. Nature (1978) 1.00
Erythropoietin sensitivity of rat bone marrow cells separated by velocity sedimentation. Cell Tissue Kinet (1970) 1.00
Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions. Mol Cell Biol (1997) 0.99
A plasma protein fractionation procedure for use in studies of protein metabolism. Biochem J (1974) 0.99
Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces. J Immunol (1986) 0.98
Model for wandering restriction enzymes. Nature (1974) 0.97
Structural basis for the preferential association of autologous immunoglobulin subunits: role of the J region of the light chain. Mol Immunol (1984) 0.97
Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies. J Biol Chem (1983) 0.97
The structure and function of the third component of human complement--I. The nature and extent of conformational changes accompanying C3 activation. Mol Immunol (1981) 0.96
Infrequent translation of a nonsense codon is sufficient to decrease mRNA level. Mol Biol Cell (1999) 0.96
Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q. J Immunol (1997) 0.95
Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain. Proc Natl Acad Sci U S A (1986) 0.95
Conformational and functional changes in the fourth component of human complement produced by nucleophilic modification and by proteolysis with C1s-. Biochemistry (1982) 0.94
Fragmentation of immunoglobulin during storage. Can J Biochem (1966) 0.93
Assembly of IgM. Role of disulfide bonding and noncovalent interactions. J Immunol (1995) 0.93
Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement. Biochemistry (1977) 0.93
Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. J Biol Chem (1992) 0.93
Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding. J Immunol (2000) 0.93
Isolation and characterization of electrophoretically homogeneous rabbit antihapten antibody populations. I. Separation and properties of homogeneous anti-p-azophenyltrimethyl-ammonium antibodies. J Biol Chem (1971) 0.92
Complement activation by IgM: evidence for the importance of the third constant domain of the mu heavy chain. Eur J Immunol (1987) 0.92
Role of the intronic elements in the endogenous immunoglobulin heavy chain locus. Either the matrix attachment regions or the core enhancer is sufficient to maintain expression. J Biol Chem (1999) 0.91
Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J (1995) 0.91
Evidence that C1t (amyloid P-component) is not a subcomponent of the first component of complement (C1). J Immunol (1977) 0.90
Structural requirements for thioester bond formation in human complement component C3. Reassessment of the role of thioester bond integrity on the conformation of C3. J Biol Chem (1992) 0.90
Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562. J Immunol (1985) 0.90
Antitoxic and antiviral antibodies in Cohn fractions of human plasma. Clin Exp Immunol (1968) 0.89
Effects of vector cutting on its recombination with the chromosomal immunoglobulin gene in hybridoma cells. Somat Cell Mol Genet (1991) 0.89
C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain. J Biol Chem (1988) 0.88
A reexamination of the role of magnesium in the human alternative pathway of complement. Mol Immunol (1986) 0.88
Production of mouse V/human C chimeric kappa genes by homologous recombination in hybridoma cells. Analysis of vector design and recombinant gene expression. J Immunol (1994) 0.88
A functional, thioester-containing alpha 2-macroglobulin homologue isolated from the hemolymph of the American lobster (Homarus americanus). J Biol Chem (1987) 0.87
The structure and binding characteristics of serum amyloid protein (9.5S alpha 1-glycoprotein). Ann N Y Acad Sci (1982) 0.87
Differential glycosylation of polymeric and monomeric IgM. Mol Immunol (1989) 0.87
Effects of mutation position on frequency of marker rescue by homologous recombination. Mol Cell Biol (1992) 0.87